Navigation Links
HollisterStier Offers Comfort With New ComforTen(TM) Multiple Skin Testing Device
Date:11/9/2007

Provides 10 puncture skin tests at once with minimal patient discomfort

SPOKANE, Wash., Nov. 9 /PRNewswire/ -- HollisterStier's Allergy Business Unit announced today the launch of the ComforTen(TM) Multiple Skin Test System, its newest allergy testing device. The device features ten surgical steel 1.2mm lancet tips, which create minimal skin trauma for comfortable allergy testing. ComforTen is the only 10-test, self-loading, surgical steel testing device on the market. ComforTen is competitively priced relative to other multiple skin test devices available today. In addition to creating a more comfortable experience for the patient; little or no trauma at the negative control site makes it easy to read skin test reactions.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060228/SFTU141LOGO)

Derek Constable, Ph.D., Director of New Product Discovery at HollisterStier, said, "ComforTen was developed with the Allergists, nurses, and the patients in mind. We have made every effort to create a comfortable allergy testing experience for all parties. We're excited to introduce this new addition to the full suite of HollisterStier products."

In addition to the device itself, the ComforTen System includes trays with three optional-use spacers (patent pending) that increase the number of tests that can be completed between fillings. "We heard allergy offices tell us they wanted a skin testing device that maximized efficiency and the ComforTen System does that," Constable said. The trays are also supplied with self-adhesive labels allowing for customized tray labeling.

When used as directed, the ComforTen device with depth control guards will produce ten reproducible skin tests resulting in well-defined reactions. The device is equipped with directional indicators to help ensure the proper orientation and application.

About HollisterStier's Allergy Business
'/>"/>

SOURCE HollisterStier Laboratories LLC
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation
2. Radio wave cooling offers new twist on laser cooling
3. Mylan Announces Pricing of Tender Offers for its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015
4. Deloitte Leadership Offers Crucial Convergence Considerations for Life Sciences Companies
5. Microtest Offers Free White Paper: Virus Testing for Biological Products: Partnering With a Contract Lab
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Amnis Announces the Release of Multiple Upgrades to the ImageStream(R) System
8. Phase 2 Data Show Daclizumab Significantly Reduced Multiple Sclerosis Lesions in Patients Receiving Interferon Beta Therapy
9. Bioponic Phytoceuticals to Roll Out Multiple Products to 1,000 Major Health Food Stores in the Western United States
10. Actelion Announces Multiple Presentations on Tracleer(R) and the REVEAL Registry at CHEST 2007
11. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...v. 23, 2009 In a provocative new study, a Univers...oxide emissions the major cause of global warming...collapses or society builds the equivalent of one ...nlikely that there will be any substantial near-te...n carbon dioxide emission rates," says the new pap...
(Date:11/23/2009)...N,Nov.23/PRNewswire-FirstCall/-YMBioSciencesInc.(N...entcompanythatidentifiesandadvancesadiverseportfol...ofdevelopment,todayreportedthatCytopia(ASX:CYT)has...87,apotent,orally-administeredJAK1/JAK2inhibitor.T...nesota.AproposaltomergeCytopiaintoYMhasbeenpreviou...
(Date:11/23/2009)...Calif.,Nov.23/PRNewswire/--Frost&Sullivan,theG...fordemonstratingleadershipandinnovationThursday,No...AwardsBanquetheldinSanAntonio,Texas. ,, (Logo: ...O ) ,, TheHealthcareInnovationAwardsaregiventoc...eliveryandmanagementofhealthcare.Suchcompanieshave...
(Date:11/20/2009)... Nov. 20 Veridiam (www.veridiam.co...ze company category at the 2009 Workplace Excellen...go Society for Human Resources Management and reco...ractices. ,, Veridiam was one of nine winners, ...panies, honored at the recent awards ceremony. San...
Breaking Biology Technology:Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2
...PRNewswire-FirstCall/ - Victhom Human Bionics Inc....ing of its updated corporate Website at www.victh... highlights advances in the Company,s two operatin...mplantable neurostimulation device for gait disord...cturing computerized prostheses for above-knee amp...
..., Jan. 9 Schering-Plough Corporation (NYSE: SGP...tion by Thomas P. Koestler, Ph.D., executive vice ...Institute, at the 27th Annual J.P. Morgan Healthca... at approximately 3:30 p.m. (PST) (6:30 p.m. EST).... R&D pipeline and select projects in developme...
... TRIANGLE PARK, N.C. and SANTA CLARA, Calif., Jan....oday that GSK has resubmitted the New Drug Applica...n (FDA) requesting approval of Solzira (TM) (gaba...he treatment of moderate-to-severe primary Restles...d that the data in a single study be reformatted. ...
Other Biology Technology:Victhom Announces Launch of Enhanced Company Website 2GSK and XenoPort Resubmit New Drug Application for Solzira(TM) in Restless Legs Syndrome 2GSK and XenoPort Resubmit New Drug Application for Solzira(TM) in Restless Legs Syndrome 3
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wildlif...ort revealing that the last remaining population o...y due to the rising tide of poaching and habitat l... inform Russian officials of what needs to be done...iggest cat. , The report was releas...
(Date:11/24/2009)..., Md. (November 24, 2009) New research on bacteri...cosystems reveals predictable temporal patterns, s...ies as markers for monitoring climate change in th... the Proceedings of the National Academy of Scien...es in the six rivers shifted synchronously over ti...
(Date:11/23/2009)...n, D.C. The community-associated strain of the de...sistant to most common antibioticsposes a far grea...ing its way into hospitals, according to a study i...ses . , The new threat is easily picked up in f...nd has increased the overall burden of MRSA within...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2New study finds MRSA on the rise in hospital outpatients 2Reward Yourself by Taking Your Dog to Obedience Training 58083 1Reward Yourself by Taking Your Dog to Obedience Training 58083 2Anthem Blue Cross and Blue Shield Awarded NCQAs Accreditation Status of Excellent 58081 1Anthem Blue Cross and Blue Shield Awarded NCQAs Accreditation Status of Excellent 58081 2Catholics to Rally at USCCB Headquarters in Washington DC Re 3A Healthcare Our Bishops and Abortion 58079 1Catholics to Rally at USCCB Headquarters in Washington DC Re 3A Healthcare Our Bishops and Abortion 58079 2
...HOUSTON -- (Nov. 19, 2008) -- Rice University scie...e stubborn pollutant TCE have created a method tha...ace of a catalyst as individual chemical bonds are...of the bonds between the atoms of our molecules," ... these vibrations change frequency and intensity w...
...MADISON, WI, NOVEMBER 17, 2008 Global land use pat...demand creative urban stormwater management. Tradi... the flow of runoff to waterways, but generally do...d by extensive pavement and compacted urban soils ...portunities affects groundwater recharge and has n...
...BOZEMAN -- The U.S. Department of Energy on Monday...stration Partnership at Montana State University t...f carbon dioxide into the sandstone rock layer ben...third and final phase of federal funding for the B...mately $14 million of the federal money will stay ...
Other Biology News:Researchers shed new light on catalyzed reactions 2Researchers shed new light on catalyzed reactions 3Urban trees enhance water infiltration 2Montana State partnership receives $66.9M for carbon sequestration 2Montana State partnership receives $66.9M for carbon sequestration 3
Mouse Anti-Protein Kinase C Beta 2 Monoclonal Antibody, Unconjugated from AbD Serotec
Mouse/Rat Anti-Canine CD3 / CD4 Dual Colour Reagent Antibody, FITC / R-Phycoerythrin Conjugated from AbD Serotec
Sheep Anti-DEHYDROEPIANDROSTERONE (+DEAHS) Polyclonal Antibody, Unconjugated from AbD Serotec
Mouse Anti-POLY (ADP-RIBOSE) (PAR) Monoclonal Antibody, Unconjugated from AbD Serotec
Biology Products: